Androgel 10 grams of gel containing 100 mg of testosterone (DrugBank: Testosterone)
8 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
1 | Spinal and bulbar muscular atrophy | 0 |
2 | Amyotrophic lateral sclerosis | 0 |
3 | Spinal muscular atrophy | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 1 |
60 | Aplastic anemia | 0 |
78 | Hypopituitarism | 0 |
113 | Muscular dystrophy | 0 |
265 | Lipodystrophy | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00405353 (ClinicalTrials.gov) | April 2002 | 28/11/2006 | Testosterone Treatment for Multiple Sclerosis | Testosterone Treatment for Multiple Sclerosis: A Preliminary Trial | Multiple Sclerosis | Drug: Androgel 10 grams of gel containing 100 mg of testosterone | University of California, Los Angeles | National Multiple Sclerosis Society | Completed | 18 Years | 65 Years | Male | 10 | Phase 1;Phase 2 | United States |